Role of neuropsychological assessment in cancer patients

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

Neurocognitive function is a very important issue in cancer survivorship. When present, neurocognitive deficits explain the lion's share of cancer survivors' reported decreased quality of life. However, scientific study of the neuropsychological sequelae of cancer is just beginning to be undertaken. A Medline search for 1996-2006 of “neuropsychology or neurocognitive” and “cancer” results in only 86 articles. Once those are selected to include only those that include information on cancer in adults (as opposed to pediatric cancer or adult survivors of pediatric cancers), written in English, only 34 papers remain. However, the relative paucity of research is in contrast to the recent attention given to this important topic, most recently in the Institute of Medicine Report From Cancer Patient to Cancer Survivor, in which cognitive dysfunction is listed as one of the important concerns of cancer survivors after treatment (Hewitt et al., 2006). Neurocognitive deficits in cancer patients are variable. When patients report having neuropsychological impairments, they may note them as being very minor (e.g., “I’m in a fog” or “I have a lot of ‘senior moments’”) or patients may have significant neurocognitive deficits that impair their ability to speak, remember, or act appropriately. Some patients are not aware of their own deficits and only caregivers have noticed the changes. A cancer patient with neurocognitive dysfunction may decline during some periods, such as during active treatment, and improve during inter-treatment intervals; however, often the opposite pattern can be seen.

Original languageEnglish (US)
Title of host publicationCognition and Cancer
PublisherCambridge University Press
Pages33-43
Number of pages11
ISBN (Electronic)9780511545900
ISBN (Print)9780521854825
DOIs
StatePublished - Jan 1 2008

Fingerprint

Neoplasms
Survivors
Pediatrics
Neuropsychology
National Academies of Science, Engineering, and Medicine (U.S.) Health and Medicine Division
Aptitude
Caregivers
Therapeutics
Survival Rate
Quality of Life
Research

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Farace, E. (2008). Role of neuropsychological assessment in cancer patients. In Cognition and Cancer (pp. 33-43). Cambridge University Press. https://doi.org/10.1017/CBO9780511545900.005
Farace, Elana. / Role of neuropsychological assessment in cancer patients. Cognition and Cancer. Cambridge University Press, 2008. pp. 33-43
@inbook{48c723b6d5f84669908fa2514de01f78,
title = "Role of neuropsychological assessment in cancer patients",
abstract = "Neurocognitive function is a very important issue in cancer survivorship. When present, neurocognitive deficits explain the lion's share of cancer survivors' reported decreased quality of life. However, scientific study of the neuropsychological sequelae of cancer is just beginning to be undertaken. A Medline search for 1996-2006 of “neuropsychology or neurocognitive” and “cancer” results in only 86 articles. Once those are selected to include only those that include information on cancer in adults (as opposed to pediatric cancer or adult survivors of pediatric cancers), written in English, only 34 papers remain. However, the relative paucity of research is in contrast to the recent attention given to this important topic, most recently in the Institute of Medicine Report From Cancer Patient to Cancer Survivor, in which cognitive dysfunction is listed as one of the important concerns of cancer survivors after treatment (Hewitt et al., 2006). Neurocognitive deficits in cancer patients are variable. When patients report having neuropsychological impairments, they may note them as being very minor (e.g., “I’m in a fog” or “I have a lot of ‘senior moments’”) or patients may have significant neurocognitive deficits that impair their ability to speak, remember, or act appropriately. Some patients are not aware of their own deficits and only caregivers have noticed the changes. A cancer patient with neurocognitive dysfunction may decline during some periods, such as during active treatment, and improve during inter-treatment intervals; however, often the opposite pattern can be seen.",
author = "Elana Farace",
year = "2008",
month = "1",
day = "1",
doi = "10.1017/CBO9780511545900.005",
language = "English (US)",
isbn = "9780521854825",
pages = "33--43",
booktitle = "Cognition and Cancer",
publisher = "Cambridge University Press",
address = "United Kingdom",

}

Farace, E 2008, Role of neuropsychological assessment in cancer patients. in Cognition and Cancer. Cambridge University Press, pp. 33-43. https://doi.org/10.1017/CBO9780511545900.005

Role of neuropsychological assessment in cancer patients. / Farace, Elana.

Cognition and Cancer. Cambridge University Press, 2008. p. 33-43.

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Role of neuropsychological assessment in cancer patients

AU - Farace, Elana

PY - 2008/1/1

Y1 - 2008/1/1

N2 - Neurocognitive function is a very important issue in cancer survivorship. When present, neurocognitive deficits explain the lion's share of cancer survivors' reported decreased quality of life. However, scientific study of the neuropsychological sequelae of cancer is just beginning to be undertaken. A Medline search for 1996-2006 of “neuropsychology or neurocognitive” and “cancer” results in only 86 articles. Once those are selected to include only those that include information on cancer in adults (as opposed to pediatric cancer or adult survivors of pediatric cancers), written in English, only 34 papers remain. However, the relative paucity of research is in contrast to the recent attention given to this important topic, most recently in the Institute of Medicine Report From Cancer Patient to Cancer Survivor, in which cognitive dysfunction is listed as one of the important concerns of cancer survivors after treatment (Hewitt et al., 2006). Neurocognitive deficits in cancer patients are variable. When patients report having neuropsychological impairments, they may note them as being very minor (e.g., “I’m in a fog” or “I have a lot of ‘senior moments’”) or patients may have significant neurocognitive deficits that impair their ability to speak, remember, or act appropriately. Some patients are not aware of their own deficits and only caregivers have noticed the changes. A cancer patient with neurocognitive dysfunction may decline during some periods, such as during active treatment, and improve during inter-treatment intervals; however, often the opposite pattern can be seen.

AB - Neurocognitive function is a very important issue in cancer survivorship. When present, neurocognitive deficits explain the lion's share of cancer survivors' reported decreased quality of life. However, scientific study of the neuropsychological sequelae of cancer is just beginning to be undertaken. A Medline search for 1996-2006 of “neuropsychology or neurocognitive” and “cancer” results in only 86 articles. Once those are selected to include only those that include information on cancer in adults (as opposed to pediatric cancer or adult survivors of pediatric cancers), written in English, only 34 papers remain. However, the relative paucity of research is in contrast to the recent attention given to this important topic, most recently in the Institute of Medicine Report From Cancer Patient to Cancer Survivor, in which cognitive dysfunction is listed as one of the important concerns of cancer survivors after treatment (Hewitt et al., 2006). Neurocognitive deficits in cancer patients are variable. When patients report having neuropsychological impairments, they may note them as being very minor (e.g., “I’m in a fog” or “I have a lot of ‘senior moments’”) or patients may have significant neurocognitive deficits that impair their ability to speak, remember, or act appropriately. Some patients are not aware of their own deficits and only caregivers have noticed the changes. A cancer patient with neurocognitive dysfunction may decline during some periods, such as during active treatment, and improve during inter-treatment intervals; however, often the opposite pattern can be seen.

UR - http://www.scopus.com/inward/record.url?scp=84926977788&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84926977788&partnerID=8YFLogxK

U2 - 10.1017/CBO9780511545900.005

DO - 10.1017/CBO9780511545900.005

M3 - Chapter

SN - 9780521854825

SP - 33

EP - 43

BT - Cognition and Cancer

PB - Cambridge University Press

ER -

Farace E. Role of neuropsychological assessment in cancer patients. In Cognition and Cancer. Cambridge University Press. 2008. p. 33-43 https://doi.org/10.1017/CBO9780511545900.005